Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

India has rejected claims that they, along with China, are the chief source of counterfeit medicines around the world.
All opioid medicines sold in the UK will be labelled with a warning as to the potential for addiction, Health Secretary Matt Hancock has announced.
Gilead has broken the news that its apoptosis signal-regulating kinase 1 (ASK1) inhibitor selonsertib failed to meet its primary endpoint at Phase...
- Senior GSK exec Richard Saynor revealed as new Sandoz CEO - J&J pay $9.9 million to settle surgical mesh implant case - Eli Lilly sell Chinese...
Eli Lilly has revealed it is to withdraw its platelet-derived growth factor receptor alpha (PDGFR-α) blocking antibody Lartruvo (olaratumab) from...
Bangladesh-based Beximco Pharma is celebrating following the decision from the FDA to approve its generic version of MSD’s antihistamine therapy...
The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK.
Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor would be...
AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches